Pharmaceutical group · India
Zydus Lifesciences
A group of 18 companies with 237 medicines in 4 countries.
Group structure
18 companies in 5 countries
Loading…
Pharmaceutical group · India
A group of 18 companies with 237 medicines in 4 countries.
18 companies in 5 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1–25 of 237
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACECLOFENACO | Aceclofenac | Brazil | Authorised | 2017 |
| ACYCLOVIR200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 400MG | 800MG · Tablet | Aciclovir | United States | Marketed | 1997 |
| ACYCLOVIR SODIUM1gm base/vial | 25mg base/ml | 500mg base/vial | 50mg base/ml · Injectable | Aciclovir | United States | Marketed | 1997 |
| ALBENDAZOLE200mg · Tablet | Albendazole | United States | Marketed | 2018 |
| ALPRAZOLAM | Alprazolam | Brazil | Authorised | 2009 |
| Alzyd | Rasagiline | Brazil | Authorised | 2024 |
| AMANTADINE HYDROCHLORIDE68.5mg base · Capsule, extended release | Amantadine | United States | Not marketed | 2024 |
| AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE10mg; 20mg | 10mg; 40mg | 2.5mg; 10mg | 5mg; 10mg | 5mg; 20mg · Capsule | Amlodipine, Benazepril | United States | Marketed | 2011 |
| AMMONIUM LACTATE12% base · Lotion | Ammonium | United States | Marketed | 2002 |
| ANDHORA | Trazodone | Brazil | Authorised | 2020 |
| APALUTAMIDE60mg · Tablet | Apalutamide | United States | Marketed | 2025 |
| apixabana | Apixaban | Brazil | Authorised | 2020 |
| ARIPIPRAZOL | Aripiprazole | Brazil | Authorised | 2016 |
| ASPIRIN AND DIPYRIDAMOLE25mg; 200mg · Capsule, extended release | Acetylsalicylic acid, Dipyridamole | United States | Marketed | 2009 |
| ATENOLOL AND CHLORTHALIDONE100mg; 25mg | 50mg; 25mg · Tablet | Atenolol, Chlorthalidone | United States | Marketed | 1990 |
| axetilcefuroxima | Axetilcefuroxima | Brazil | Authorised | 2025 |
| benzoato de rizatriptana | Rizatriptan benzoato | Brazil | Authorised | 2023 |
| BROMOCRIPTINE MESYLATE5mg base · Capsule | Bromocriptine | United States | Marketed | 1998 |
| CANDESARTAN CILEXETIL16mg | 32mg | 4mg | 8mg · Tablet | Candesartan cilexetil | United States | Marketed | 2013 |
| CARBIDOPA25mg · Tablet | Carbidopa | United States | Marketed | 2014 |
| carbidopa + levodopa | Carbidopa, Levodopa | Brazil | Authorised | 2023 |
| carvedilol | Carvedilol | Brazil | Authorised | 2019 |
| celecoxibe | Celecoxib | Brazil | Authorised | 2019 |
| CITALOPRAM | Citalopram | Brazil | Authorised | 2006 |
| citrato de sildenafila | Sildenafil | Brazil | Authorised | 2019 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Brazil | 136 | 101 | 35 | CompaniesAll medicines |
| United States | 79 | 65 | 14 | CompaniesAll medicines |
| Canada | 14 | 14 | 0 | CompaniesAll medicines |
| Saudi Arabia | 8 | 8 | 0 | CompaniesAll medicines |
Also in the registers of Colombia, France, Malaysia, Singapore, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date
Licence: Other (Public Domain)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, https://dados.anvisa.gov.br/dados/CONSULTAS/EMPRESA_FISCALIZACAO_PRODUTO/TA_CONSULTA_CBPF_MEDICAMENTO_DETALHE.CSV; source modified Fri, 15 May 2026 07:52:35 GMT; acquired 2026-10-18T08:23:43.211112+00:00; original factual values retained, no endorsement.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Agência Nacional de Vigilância Sanitária (Anvisa), DATAVISA open-data register; source modification 2026-10-07, acquired 2026-10-07 UTC.
Licence: Brazil federal open-data reuse, Decreto 8777/2016, consolidated article 4 as amended by Decreto 9903/2019
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vencidos; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes; source update 2026-09-16; acquired 2026-10-08.
Report an error or request removalCorrections from the company itself are welcome.
Keep Zydus Lifesciences’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callLicence: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes, dataset i7cb-raxc, rowsUpdatedAt 1792152574, acquired 2026-10-26; original values retained.
Licence: CC BY-SA 4.0
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
BDPM / ANSM, HAS and UNCAM, CIS_MITM.txt, published 13/10/2026, acquired 2026-10-25T22:15:46.803459+00:00; exact facts retained, no endorsement.
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; https://www.gov.uk/government/publications/marketing-authorisations-granted-in-2026; publication updated 7 October 2026; source PDF periods January–September 2026; original bytes acquired 18 October 2026; PDF page/table/exact-authorisation projections by Prognia under OGL v3.0.
Licence: Open Government Licence v3.0; GOV.UK Crown copyright publication and linked factual MHRA grant registers
National Pharmaceutical Regulatory Agency and Ministry of Health Malaysia, KKMNOW Approved Pharmaceutical Products, https://data.moh.gov.my/data-catalogue/pharmaceutical_products; CC BY 4.0; original data as of 2026-09-30 23:59; acquired 2026-10-16T22:34:39.948031+00:00; Prognia preserves original records and projects exact MAL IDs and category/role fields. No government endorsement implied.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0), exact MOH dataset dedication
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
U.S. Food and Drug Administration, Drugs@FDA API last updated 2026-10-23; full fixed 19-ID query acquired 2026-10-24T09:17:53.209180+00:00. Original facts retained; Prognia exact ID projection and later-reference resolution; no FDA endorsement.
Licence: openFDA factual NDC data, Creative Commons CC0 1.0 Universal / public domain, third-party and source-listing exceptions retained
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licence: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Well-known pharmaceutical groups, each with all its companies.
Ranked by their number of medicines.